SEC 13F Intelligence

Managers / Q4 2023 · view latest →

MVM Partners, LLC

CIK 0001947083 · OLD CITY HALL, 45 SCHOOL STREET, BOSTON, MA, 02108 · 617-383-2101

Reported Value
$172M
Q4 2023
Positions
3
Filings on Record
14
2019–present window
Filed
Feb 12, 2024
original filing

Summary

Mvm Partners, LLC reported $172M in U.S.-listed holdings across 3 positions for Q4 2023.

The portfolio is heavily concentrated: Paragon 28 alone accounts for 78.6% of reported value.

Compared with Q4 2022, the fund opened 1 new position and exited 1.

Portfolio Metrics

Turnover
+7.7%
vs prior filed quarter
Largest Position
+78.6%
Paragon 28
New / Exited
1 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’22: $294MQ4 ’22Q4 ’23: $172MQ1 ’24: $167MQ1 ’24Q2 ’24: $100MQ3 ’24: $92MQ3 ’24Q4 ’24: $124MQ1 ’25: $79MQ1 ’25Q2 ’25: $10MQ3 ’25: $22MQ3 ’25Q4 ’25: $17MQ1 ’26: $11MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 78.6%Other: 21.4%
  • Common Stock · 78.6% · $135M
  • Other · 21.4% · $37M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2022 (amended baseline) · note: prior filed quarter, not the immediately preceding one

IssuerMoveShare ΔShares nowValue ΔValue now
MDXHEALTH SANEW+4.55M4.55M+$18M$18M
MDXHEALTH SASOLD OUT916.7K0$6M$0
PARAGON 28 INCTRIMMED2.77M10.89M$126M$135M
OPTINOSE INCHELD+014.61M$8M$19M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

3 positions
#IssuerClass% PortfolioValueShares
1PARAGON 28 INCCOM78.62%$135M10.89M
2OPTINOSE INCCOM10.94%$19M14.61M
3MDXHEALTH SACOM10.44%$18M4.55M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$11M1May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$17M1Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$22M1Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$10M1Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$79M3May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$124M3Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$92M3Nov 1, 202413F-HRchanges · EDGAR ↗
Q2 2024$100M3Jul 25, 202413F-HRchanges · EDGAR ↗
Q1 2024$167M3May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$172M3Feb 12, 202413F-HRchanges · EDGAR ↗
Q4 2022$294M3Feb 13, 202313F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.